This is a $7,592.40 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4565256886 BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of July 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product. The contract has a ceiling value of $7,882.88 and a period of performance through April 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $2,636.60 and a performance period through May 19, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor and has a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The fixed-price contract has a ceiling value of $15,819.60 and an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The delivery order has a ceiling value of $1,021.72 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger $999,999,999.00 indefinite delivery contract the company holds with DLA to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a firm fixed price ceiling value of $15,555.94. The contract has an ultimate completion date of May 13, 2025. This appears to be a delivery order contract, without a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,862.63, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,330.50, is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5ML) with a completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a ceiling value of $4,412.90 and a period of performance through May 30, 2025. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP Vaccine Syringes. The contract has a ceiling value of $1,021.72 and an ultimate completion date of September 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held...